NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Stephen KL Chia
British Columbia Cancer Agency - Vancouver / Canada
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4375091
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Stephen KL Chia's MOST POPULAR ARTICLES
1-)
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ...JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 200928252009
2-)
The clonal and mutational evolution spectrum of primary triple-negative breast cancersSP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...Nature 486 (7403), 395-399, 201220472012
3-)
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMCU Cheang, D Voduc, C Bajdik, S Leung, S McKinney, SK Chia, ...Clinical cancer research 14 (5), 1368-1376, 200815892008
4-)
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early …A Schneeweiss, S Chia, T Hickish, V Harvey, A Eniu, R Hegg, C Tausch, ...Annals of oncology 24 (9), 2278-2284, 201313852013
5-)
Phase III randomized study of ribociclib and fulvestrant in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: MONALEESA-3DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, ...Journal of Clinical Oncology 36 (24), 2465-2472, 201810962018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept